Can you eradicate HPV?

Can you eradicate HPV?

HPV can clear up naturally – as there is no cure for the underlying HPV infection, the only way to get rid of HPV is to wait for the immune system to clear the virus naturally.

Is HPV vaccine recommended?

HPV vaccine is recommended for routine vaccination at age 11 or 12 years. (Vaccination can be started at age 9.) ACIP also recommends vaccination for everyone through age 26 years if not adequately vaccinated when younger.

Why is HPV a public health concern?

Low-risk HPV causes anogenital warts and recurrent respiratory papillomatosis, a rare but important condition in which warts grow in the throat and airway. Most infections cause no symptoms and are not clinically significant, but persistent infection can lead to disease or cancer.

READ ALSO:   Can you make a game using Visual Studio?

Is it worth having HPV vaccine if you have HPV?

If I have or have had HPV, should I get the HPV vaccine? The HPV vaccine cannot get rid of an HPV infection you already have. However, it does prevent infection with other types of HPV and prevents reinfection with the same type. So if you already have HPV it could still benefit you to have the vaccine.

Which of the following patients would be an appropriate candidate for the HPV vaccine?

Which of the following patients would be an appropriate candidate for the HPV vaccine? The HPV vaccine is recommended for all adolescents ages 11 through 12 years of age. It may be given as early as age 9 if there is a history of sexual abuse or assault.

Who HPV elimination?

Achieving elimination Vaccination: 90\% of girls fully vaccinated with the HPV vaccine by the age of 15; Screening: 70\% of women screened using a high-performance test by the age of 35, and again by the age of 45; Treatment: 90\% of women with pre-cancer treated and 90\% of women with invasive cancer managed.

READ ALSO:   Is 98 a good CAT percentile?

Is HPV a chronic disease?

Most infections by human papillomaviruses (HPVs) are ‘acute’, that is non-persistent. Yet, for HPVs, as for many other oncoviruses, there is a striking gap between our detailed understanding of chronic infections and our limited data on the early stages of infection.